Cinnamon: using the spice for colds, coughs, and diabetes — what science says

Editorial Note

This article was originally published in the past and has been updated according to scientific and divulgative criteria. It is for informational purposes only and does not replace medical advice: for diagnoses, therapies, or clinical decisions, always consult a healthcare professional.

IN BRIEF

• Cinnamon is a spice with ancient medicinal applications; modern evidence shows plausible biological effects but variable clinical results.
• For glycemic control, meta-analyses report modest reductions dependent on the dose, duration, and preparation of the spice.
• Cinnamon and its active ingredient (cinnamaldehyde) show antimicrobial activity in the laboratory, but solid clinical evidence is lacking for treating colds or coughs.
• Cassia (common in supermarkets) contains higher levels of coumarin than Ceylon; chronically high intake can pose a liver risk.

Abstract: What does science say?

Cinnamon (Cinnamomum spp.) is a spice used in cooking and traditional medicine. Experimental studies identify active compounds—especially cinnamaldehyde and phenolic compounds—with antimicrobial, anti-inflammatory activity, and potential effects on glucose metabolism. Reviews and meta-analyses of clinical studies indicate modest and non-uniform effects on glycemic control in people with hyperglycemia or type 2 diabetes: some studies show reductions in fasting glycemia or certain lipid variables, while others do not confirm clinically relevant benefits. The difference between botanical species (Cassia versus Ceylon), the composition of preparations (powder, extract, dose), and the duration of intake influence the results. There are safety signals related to coumarin, especially with repeated or high-dose consumption, with possible liver effects. In the context of colds and coughs, most evidence comes from in vitro studies or non-clinical models: this means therapeutic application is not supported by robust evidence. Overall, cinnamon is plausibly beneficial in some contexts as an adjuvant, but the evidence does not justify absolute claims or substitutions for established therapies.

History, Botany, and Traditional Uses

Cinnamon has been used as a spice and remedy in many cultures for millennia. In botany, the term "cinnamon" includes several species of the genus Cinnamomum; the two most commercially relevant are Cinnamomum verum (called "Ceylon" or "true cinnamon") and various Cassia species (often referred to as "cassia" or "Chinese cinnamon"). The botanical differences are reflected in the chemical composition of the bark and its uses: Ceylon tends to have a more delicate aroma and very low levels of coumarin, while Cassia is commonly cheaper and richer in coumarin.

Historically, the spice has been valued for flavoring foods, as a preservative, and in folk remedies for respiratory and digestive symptoms. In traditional medicine (Chinese, Ayurvedic), cinnamon frequently appears for its presumed warming effect, to aid digestion, and to soothe minor ailments. These traditional uses have stimulated modern research that has evaluated individual components and possible mechanisms of action.

Types of Cinnamon: Cassia and Ceylon

From a practical standpoint, it is useful to distinguish between the two main commercial families. Cassia (C. cassia or C. aromaticum) is the most common in supermarkets: it has a strong aroma and a significantly higher coumarin content. Ceylon (C. verum) is considered "true" or premium and is characterized by a lower coumarin content and a more delicate aromatic profile. This distinction is important for safety in cases of frequent or high-dose use, because coumarin can be hepatotoxic if taken in sustained quantities over time. Furthermore, recent studies highlight authenticity and adulteration issues in commercial products, with frequent substitutions or mislabeling that complicate safe use and research interpretation [10].

Biological Properties and Possible Mechanisms

The main components of cinnamon include cinnamaldehyde, polyphenols, and minor molecules such as eugenol and coumarin. In cellular and animal models, cinnamaldehyde shows antimicrobial activity and the ability to interfere with bacterial or cellular membranes, as well as effects on inflammatory pathways and metabolic signals [6].

Regarding metabolic mechanisms, experimental evidence suggests that some cinnamon extracts may improve insulin signaling, increase the expression of glucose transporters, and modulate inflammatory and oxidative pathways involved in insulin resistance [9]. These mechanisms are plausible and support the biological hypothesis of a favorable effect on glycemia and lipid profile, but the translation into lasting clinical benefits requires confirmation in quality controlled studies.

Antimicrobial and Antifungal: What Experimental Research Shows

Numerous in vitro studies and some food experiments show that cinnamon extracts or purified cinnamaldehyde reduce the growth of common bacteria and fungi: Escherichia coli, Staphylococcus aureus, and Candida species are among the organisms studied. These effects are dose-dependent and observed at concentrations that often exceed those achievable with ordinary culinary use; therefore, laboratory demonstration does not equate to clinical efficacy in treating respiratory or digestive tract infections [6][7][8].

Clinical Evidence on Diabetes and Glycemic Control

The most studied question in the clinical field concerns the effect of cinnamon on glucose metabolism in people with prediabetes or type 2 diabetes. Over the past fifteen to twenty years, numerous clinical trials, systematic reviews, and meta-analyses have been conducted, reporting variable results due to differences in studied populations, type of preparation (powder, extract), dose (from a few hundred to 3,000 mg/day or more), and duration (a few weeks up to about 4 months) [1][2].

A more recent dose-response analysis combined RCTs and did not find a consistent effect on HbA1c across all studies, although it did note modest reductions in fasting glycemia at doses below certain values and improvements in some lipid parameters in subgroups [1]. Some individual controlled studies, however, reported reductions in HbA1c and fasting glycemia, but the results are not universally replicated, and the clinical significance remains modest and context-dependent [3][4].

Main Research and Interpretation

Recent meta-analyses and reviews converge on the fact that cinnamon can exert a favorable, but limited in magnitude, effect on short-term glycemic control. Several factors influence the outcome: the botanical species used, the eventual standardization of the extract, the participants' concomitant drug therapy, and the study duration [2][1]. In practice, cinnamon is considered a possible adjuvant to be evaluated in the context of lifestyle interventions and established pharmacological therapy, but not a substitute for prescribed diabetes treatments.

Cinnamon for Colds and Coughs: What Do We Know?

Many traditional uses of cinnamon concern respiratory ailments (colds, coughs). Modern scientific documentation on these uses is limited: most evidence comes from in vitro studies or folk traditions not validated in controlled clinical RCTs. Experimental studies indicate that cinnamon extracts have antimicrobial and antiviral activity in the laboratory, but these results do not constitute proof of efficacy in reducing the duration or intensity of colds or coughs in the general population [6][7].

Traditional Use and Limitations of Evidence

The use of cinnamon in teas, infusions, or as an ingredient in home remedies can offer subjective relief due to aromatic effects, stimulation of the cough reflex, or mild local antiseptic properties. However, to recommend cinnamon as a specific treatment against respiratory infections, well-conducted clinical studies would be needed, which are currently lacking; therefore, the evidence does not support therapeutic claims for colds and coughs.

Risks, Interactions, and Dosages

The safety profile of cinnamon depends on the botanical species and the amount consumed. Cassia tends to contain much higher levels of coumarin than Ceylon; coumarin is associated with liver effects in animal studies and clinical reports when exposure is prolonged or at high doses [5][10]. European scientific authorities have indicated limits for coumarin (tolerable daily intake, TDI), and recent studies have highlighted authenticity issues and commercial samples with high coumarin, with possible risks for consumers, particularly children.

Other adverse effects reported in reviews include gastrointestinal disturbances and allergic reactions in sensitive individuals. Documented drug interactions are limited but theoretically possible: the effect on glucose metabolism could potentiate the action of hypoglycemic drugs if taken concomitantly at high doses. Precautions: avoid self-administered therapeutic doses during pregnancy without medical consultation and limit chronic intake of high amounts of Cassia [5].

Coumarin: What's Important to Know

Coumarin is a natural compound present in significant quantities, especially in Cassia. Chronic exposure to high amounts of coumarin has been associated with reports of liver toxicity; for this reason, many guidelines and reviews recommend caution with high doses and prolonged use, preferring, when possible, Ceylon or standardized preparations with low coumarin content [5][10].

What This Means in Practice

For the general public: using cinnamon as a spice in cooking is generally safe for most people. If regular use for health reasons (e.g., to help control glycemia) is considered, it is important to know that clinical benefits are modest and not always consistent. Evaluating the species (Ceylon vs. Cassia) can reduce the risk of high coumarin exposure; prefer certified products and, for prolonged or therapeutic use, consult your doctor or a pharmacist, especially if you are taking hypoglycemic medications.

For cold and cough symptoms, the use of warm infusions with cinnamon can offer subjective relief but does not replace medical care or advice. In the presence of high fever, respiratory difficulties, or worsening symptoms, consult a healthcare professional.

KEY POINTS TO REMEMBER

• Clinical evidence indicates modest and non-uniform effects of cinnamon on glycemic control; it is not a substitute therapy for medical treatment. [1]
• Experimental data confirm the antimicrobial activity of cinnamaldehyde, but solid clinical evidence for the treatment of colds and coughs is lacking. [6][7]
• The species and quality of the product matter: Cassia contains more coumarin than Ceylon; high and prolonged consumption can entail risks. [5][10]
• For regular use for health purposes, consult a healthcare professional and prefer traceable products. [5]

Limitations of Evidence

The differences between observational studies and RCTs: many preclinical and observational studies indicate biological plausibility, but only randomized controlled clinical trials can effectively evaluate causality. In the available reviews and meta-analyses, heterogeneity of doses, preparations, duration, and studied populations limits the ability to draw definitive conclusions. The methodological quality of some trials is low or moderate, and the presence of small studies increases the risk of overestimating effects. Furthermore, commercial variability (species of origin, adulteration, coumarin content) complicates the replication and practical application of studies in domestic or clinical settings. For these reasons, it is necessary to interpret the results with caution and prioritize recommendations based on robust and contextualized evidence.

Editorial Conclusion

Cinnamon remains a spice with a long history of use and a biochemical profile that justifies scientific research. Modern evidence indicates potentially useful effects on glucose metabolism and antimicrobial properties in the laboratory, but clinical efficacy for diabetes is modest and not universally confirmed; for colds and coughs, clinical evidence is insufficient. The main concern for regular use is safety: choose traceable products, prefer Ceylon if daily consumption is planned, and consult a doctor in case of concomitant therapies or relevant health conditions. Future research should improve the standardization of preparations, the size and quality of studies to establish with greater certainty roles, dosages, and limits of use.

Editorial Note (final)

Article updated following transparency and source verification criteria. The purpose is to inform in a neutral, accessible, and evidence-based manner. This content is not a source of personalized clinical advice.

SCIENTIFIC RESEARCH

1. Yu T, Lu K, Cao X, Xia H, Wang S, Sun G, Chen L, Liao W. The Effect of Cinnamon on Glycolipid Metabolism: A Dose–Response Meta‑Analysis of Randomized Controlled Trials. Nutrients. 2023;15:2983. https://doi.org/10.3390/nu15132983
2. Davis PA, Yokoyama W. Cinnamon intake lowers fasting blood glucose: meta‑analysis. J Med Food. 2011;14(9):884‑889. https://doi.org/10.1089/jmf.2010.0180
3. Akilen R, Tsiami A, Devendra D, Robinson N. Glycated haemoglobin and blood pressure‑lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo‑controlled, double‑blind clinical trial. Diabet Med. 2010;27(10):1159‑1167. https://doi.org/10.1111/j.1464-5491.2010.03079.x
4. Mang B, Wolters M, Schmitt B, et al. Effects of a cinnamon extract on plasma glucose, HbA1c, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest. 2006;36(5):340‑344. https://doi.org/10.1111/j.1365-2362.2006.01629.x
5. Hajimonfarednejad M, Ostovar M, Raee MJ, et al. Cinnamon: A systematic review of adverse events. Clin Nutr. 2019;38(2):594‑602. https://doi.org/10.1016/j.clnu.2018.03.013
6. Li X, Zhang L, et al. Antibacterial Mechanism of Cinnamaldehyde: Modulation of Biosynthesis of Phosphatidylethanolamine and Phosphatidylglycerol in Staphylococcus aureus and Escherichia coli. J Agric Food Chem. 2021. https://doi.org/10.1021/acs.jafc.1c04977
7. Rendon‑Macias E, et al. A review of cinnamaldehyde and its derivatives as antibacterial agents. Fitoterapia. 2019; (review). https://doi.org/10.1016/j.fitote.2019.104405
8. Santos H.O., et al. Antifungal Activity of a Mixture of Cinnamaldehyde and Eugenol Against Candida spp. Antibiotics. 2022;11(1):73. https://doi.org/10.3390/antibiotics11010073
9. Sheng X.Y., et al. Improved Insulin Resistance and Lipid Metabolism by Cinnamon Extract through Activation of Peroxisome Proliferator‑Activated Receptors. PPAR Res. 2008;2008:581348. https://doi.org/10.1155/2008/581348
10. Gonçalves F, et al. High rate of safety and fraud issues in commercially available cinnamon. npj Sci Food. 2025. https://doi.org/10.1038/s41538-025-00485-w